4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-24-000146
Co-Chief Executive Officer acquired 315,681 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-03 | Option exercise : show line 1 in the form | +315,681 | $1.58 | $498,776 | 10,199,776 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-03 | Option exercise : show line 2 in the form Warrant (right to buy) | −315,681 | 0 | I |
Loading xslF345X05/wk-form4_1727988861.xml…